FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743370548> ?p ?o ?g. }

• W2743370548 endingPage "2422" @default.
• W2743370548 startingPage "2410" @default.
• W2743370548 abstract "Primary HPV screening enables earlier diagnosis of cervical lesions compared to cytology, however, its effect on the risk of treatment and adverse obstetric outcomes has not been extensively investigated. We estimated the cumulative lifetime risk (CLR) of cervical cancer and excisional treatment, and change in adverse obstetric outcomes in HPV unvaccinated women and cohorts offered vaccination (>70% coverage in 12–13 years) for the Australian cervical screening program. Two-yearly cytology screening (ages 18–69 years) was compared to 5-yearly primary HPV screening with partial genotyping for HPV16/18 (ages 25–74 years). A dynamic model of HPV transmission, vaccination, cervical screening and treatment for precancerous lesions was coupled with an individual-based simulation of obstetric complications. For cytology screening, the CLR of cervical cancer diagnosis, death and treatment was estimated to be 0.649%, 0.198% and 13.4% without vaccination and 0.182%, 0.056% and 6.8%, in vaccinated women, respectively. For HPV screening, relative reductions of 33% and 22% in cancer risk for unvaccinated and vaccinated women are predicted, respectively, compared to cytology. Without the implementation of vaccination, a 4% increase in treatment risk for HPV versus cytology screening would have been expected, implying a possible increase in pre-term delivery (PTD) and low birth weight (LBW) events of 19 to 35 and 14 to 37, respectively, per 100,000 unvaccinated women. However, in vaccinated women, treatment risk will decrease by 13%, potentially leading to 4 to 41 fewer PTD events and from 2 more to 52 fewer LBW events per 100,000 vaccinated women. In unvaccinated women in cohorts offered vaccination as 12–13 year olds, no change to lifetime treatment risk is expected with HPV screening. In unvaccinated women in cohorts offered vaccination as 12–13 year olds, no change to lifetime treatment risk is expected with HPV screening. HPV screening starting at age 25 in populations with high vaccination coverage, is therefore expected to both improve the benefits (further decrease risk of cervical cancer) and reduce the harms (reduce treatments and possible obstetric complications) associated with cervical cancer screening." @default.
• W2743370548 created "2017-08-17" @default.
• W2743370548 creator A5000592358 @default.
• W2743370548 creator A5007964616 @default.
• W2743370548 creator A5023209389 @default.
• W2743370548 creator A5047316592 @default.
• W2743370548 creator A5052465499 @default.
• W2743370548 creator A5058594959 @default.
• W2743370548 creator A5070990563 @default.
• W2743370548 creator A5076658140 @default.
• W2743370548 creator A5083637480 @default.
• W2743370548 creator A5084310936 @default.
• W2743370548 creator A5084421941 @default.
• W2743370548 creator A5089919359 @default.
• W2743370548 date "2017-10-05" @default.
• W2743370548 modified "2023-10-14" @default.
• W2743370548 title "How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination" @default.
• W2743370548 cites W1578545435 @default.
• W2743370548 cites W1974996317 @default.
• W2743370548 cites W1976803477 @default.
• W2743370548 cites W1994244696 @default.
• W2743370548 cites W1997592201 @default.
• W2743370548 cites W2013787330 @default.
• W2743370548 cites W2049579473 @default.
• W2743370548 cites W2057399760 @default.
• W2743370548 cites W2086334567 @default.
• W2743370548 cites W2121732950 @default.
• W2743370548 cites W2124403004 @default.
• W2743370548 cites W2126945850 @default.
• W2743370548 cites W2153952034 @default.
• W2743370548 cites W2158899578 @default.
• W2743370548 cites W2253806546 @default.
• W2743370548 cites W2400551155 @default.
• W2743370548 cites W2489063059 @default.
• W2743370548 cites W2512321320 @default.
• W2743370548 cites W2530408327 @default.
• W2743370548 cites W2539516142 @default.
• W2743370548 cites W2586260676 @default.
• W2743370548 cites W2740941536 @default.
• W2743370548 doi "https://doi.org/10.1002/ijc.30926" @default.
• W2743370548 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28801947" @default.
• W2743370548 hasPublicationYear "2017" @default.
• W2743370548 type Work @default.
• W2743370548 sameAs 2743370548 @default.
• W2743370548 citedByCount "22" @default.
• W2743370548 countsByYear W27433705482018 @default.
• W2743370548 countsByYear W27433705482019 @default.
• W2743370548 countsByYear W27433705482020 @default.
• W2743370548 countsByYear W27433705482021 @default.
• W2743370548 countsByYear W27433705482022 @default.
• W2743370548 countsByYear W27433705482023 @default.
• W2743370548 crossrefType "journal-article" @default.
• W2743370548 hasAuthorship W2743370548A5000592358 @default.
• W2743370548 hasAuthorship W2743370548A5007964616 @default.
• W2743370548 hasAuthorship W2743370548A5023209389 @default.
• W2743370548 hasAuthorship W2743370548A5047316592 @default.
• W2743370548 hasAuthorship W2743370548A5052465499 @default.
• W2743370548 hasAuthorship W2743370548A5058594959 @default.
• W2743370548 hasAuthorship W2743370548A5070990563 @default.
• W2743370548 hasAuthorship W2743370548A5076658140 @default.
• W2743370548 hasAuthorship W2743370548A5083637480 @default.
• W2743370548 hasAuthorship W2743370548A5084310936 @default.
• W2743370548 hasAuthorship W2743370548A5084421941 @default.
• W2743370548 hasAuthorship W2743370548A5089919359 @default.
• W2743370548 hasBestOaLocation W27433705481 @default.
• W2743370548 hasConcept C121608353 @default.
• W2743370548 hasConcept C126322002 @default.
• W2743370548 hasConcept C131872663 @default.
• W2743370548 hasConcept C142724271 @default.
• W2743370548 hasConcept C18823058 @default.
• W2743370548 hasConcept C197934379 @default.
• W2743370548 hasConcept C203014093 @default.
• W2743370548 hasConcept C22070199 @default.
• W2743370548 hasConcept C2777343196 @default.
• W2743370548 hasConcept C2778220009 @default.
• W2743370548 hasConcept C2780647465 @default.
• W2743370548 hasConcept C29456083 @default.
• W2743370548 hasConcept C71924100 @default.
• W2743370548 hasConceptScore W2743370548C121608353 @default.
• W2743370548 hasConceptScore W2743370548C126322002 @default.
• W2743370548 hasConceptScore W2743370548C131872663 @default.
• W2743370548 hasConceptScore W2743370548C142724271 @default.
• W2743370548 hasConceptScore W2743370548C18823058 @default.
• W2743370548 hasConceptScore W2743370548C197934379 @default.
• W2743370548 hasConceptScore W2743370548C203014093 @default.
• W2743370548 hasConceptScore W2743370548C22070199 @default.
• W2743370548 hasConceptScore W2743370548C2777343196 @default.
• W2743370548 hasConceptScore W2743370548C2778220009 @default.
• W2743370548 hasConceptScore W2743370548C2780647465 @default.
• W2743370548 hasConceptScore W2743370548C29456083 @default.
• W2743370548 hasConceptScore W2743370548C71924100 @default.
• W2743370548 hasFunder F4320334705 @default.
• W2743370548 hasFunder F4320334715 @default.
• W2743370548 hasIssue "12" @default.
• W2743370548 hasLocation W27433705481 @default.
• W2743370548 hasLocation W27433705482 @default.
• W2743370548 hasLocation W27433705483 @default.
• W2743370548 hasOpenAccess W2743370548 @default.

• next